Modelling direct healthcare costs for screening and treatment of retinopathy of prematurity among infants born at gestational age <24 weeks: findings from a Swedish cohort
Chatarina Löfqvist, Shambhavi Sharma, Ann Hellström, Hanna Gyllensten · 2025
Read Modelling direct healthcare costs for screening and treatment of retinopathy of prematurity among infants born at gestational age <24 weeks: findings from a Swedish cohort by Chatarina Löfqvist, Shambhavi Sharma, Ann Hellström, Hanna Gyllensten (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12766756.txt.
Description
Chatarina Löfqvist, Shambhavi Sharma, Ann Hellström, and Hanna Gyllensten model eye care costs for the earliest preterm infants in a 2025 paper. Sweden actively treats babies born at 22 to 23 weeks, who face high risk of a blinding retinal disease. The cohort covers all 399 such infants screened from 2007 to 2018.
The cost model splits care into no sight saving treatment, laser first, or anti growth factor injection first. Thirty-six percent got laser, averaging sixteen screenings, and seven percent got injections, averaging twenty-five. Cost per treated infant ran near 18,590 international dollars for laser and 20,792 for injections. The injection path's heavier screening load raises cost effectiveness questions despite similar totals.
Catalog record
| CREATOR | Chatarina Löfqvist, Shambhavi Sharma, Ann Hellström, Hanna Gyllensten |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |